CellSource Co., Ltd.
4880
Rank in Stocks
#24108
CellSource Co., Ltd. operates within both the regenerative medicine and... CellSource Co., Ltd. operates within both the regenerative medicine and consumer product sectors. Among its offerings is Signalift, an anti-aging solution. The company, which was established in 2015, is headquartered in Tokyo, Japan.
Share Price
$1.81
Last synced: 2026-11-10
Market Cap
$35.94M
Change (1 day)
1.78%
Change (1 year)
-45.10%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade CellSource Co., Ltd. (4880)
Category
Healthcare
Operating Margin for CellSource Co., Ltd. (4880)
Operating Margin as of November 2026 TTM: 6.45%
According to CellSource Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 6.45%. At the end of 2025 the company had an operating margin of 4.49%.
Operating Margin history for CellSource Co., Ltd. from 2017 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 6.45% | 43.65% |
| 2025 | 4.49% | 51.18% |
| 2024 | 2.97% | -89.03% |
| 2023 | 27.08% | -26.33% |
| 2022 | 36.76% | 8.24% |
| 2021 | 33.96% | 51.61% |
| 2020 | 22.40% | 10.40% |
| 2019 | 20.29% | -16.61% |
| 2018 | 24.33% | -20.65% |
| 2017 | 30.66% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -94.02% |
US
|
|
| -149.01% | -123.10% |
US
|
|
| 25.57% | -96.04% |
AU
|
|
| 31.23% | -95.16% |
BE
|
|
| 29.35% | -95.45% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about CellSource Co., Ltd.'s operating margin
What is CellSource Co., Ltd.'s operating margin?
CellSource Co., Ltd.'s operating margin is 6.45%, as of Nov 2026.
What was CellSource Co., Ltd.'s operating margin in 2025?
In 2025, CellSource Co., Ltd.'s operating margin was 4.49%, compared with 2.97% in 2024.
How has CellSource Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, CellSource Co., Ltd.'s operating margin was highest in 2022 (36.76%) and lowest in 2024 (2.97%).
How does CellSource Co., Ltd.'s operating margin compare with similar companies?
CellSource Co., Ltd.'s operating margin (6.45%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.